RSLBF:OTC-RaySearch Laboratories AB (publ) (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 14.44

Change

0.00 (0.00)%

Market Cap

USD 0.44B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
PMCUF Pro Medicus Limited

N/A

USD 9.09B
MTHRF M3 Inc

N/A

USD 7.35B
MTHRY M3 Inc

N/A

USD 6.33B
PANHF Ping An Healthcare and Technol..

N/A

USD 1.67B
SMSSY SMS Co., Ltd.

N/A

USD 1.12B
SMSZF SMS Co. Ltd

N/A

USD 1.07B
CRWRF Craneware plc

N/A

USD 1.06B
SUSRF Surgical Science Sweden AB (pu..

N/A

USD 0.74B
SFSVF Software Service, Inc.

N/A

USD 0.50B
KSIOF kneat.com inc.

N/A

USD 0.27B

ETFs Containing RSLBF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 55.27% 78% C+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.27% 78% C+ 88% B+
Trailing 12 Months  
Capital Gain 123.88% 93% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 123.88% 93% A 93% A
Trailing 5 Years  
Capital Gain 9.39% 83% B 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.39% 83% B 65% D
Average Annual (5 Year Horizon)  
Capital Gain 1.87% 56% F 43% F
Dividend Return 1.87% 55% F 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 43.85% 62% D 55% F
Risk Adjusted Return 4.25% 56% F 38% F
Market Capitalization 0.44B 92% A 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector